Staff Reports
Emma Heming Willis showed up in the California Capitol to do what elected officials sometimes won’t: push for action. She urged lawmakers to pass SB 1047 so frontotemporal degeneration — FTD — gets counted in California’s neurodegenerative disease registry. That’s the clear ask: add FTD to the state list, extend the registry, and give researchers better data. The bill now sits on the Assembly’s suspense file with the clock ticking.
What SB 1047 Would Do for FTD and Research
SB 1047, authored by Senator Roger Niello with Senator Ben Allen as co‑author, would require the California Department of Public Health (CDPH) to collect reports of FTD and related dementias and keep that data in the Neurodegenerative Disease Registry. The idea is simple: doctors report, the state counts, researchers get a better picture of how many Californians are affected. The bill also pushes the registry’s expiration date out so it keeps running through the next decade — but only if funding is provided and the department has the staff and IT to do the work.
Why Emma Heming Willis Went to Sacramento
Emma Heming Willis is not a lobbyist by trade, but she has a clear motive: her husband’s diagnosis made this real for her family. Advocates say FTD is often missed or misdiagnosed, and that you can’t study what you don’t count. Celebrity attention moves the needle — it gets headlines and pressure on lawmakers. That’s useful. Compassion and visibility matter when families are lost in a maze of uncertainty, and anyone who’s watched a loved one decline wants answers and faster progress on treatments.
Legislative Reality, Costs, and Common‑Sense Questions
Here’s where the cheerleader moment meets the grown‑ups’ table. SB 1047 was put on the Assembly suspense file, meaning appropriators are weighing costs and tradeoffs. Public documents show the registry needs staff and new IT work to operate properly, and implementation depends on appropriated funds. Reports have floated an annual cost, but precise figures should be produced by the Assembly Appropriations Committee or CDPH budget office — not passed around like rumor. Conservatives should support research and care, but we should also demand clear budgets, timelines, privacy protections, and limits on new reporting mandates for front‑line clinicians.
A Conservative Way Forward: Compassion With Accountability
We can do two things at once: back families and keep taxpayer dollars honest. Lawmakers should vote with urgency for better data on FTD, but only with safeguards — clear funding lines, strict confidentiality rules, a sunset review, and measurable goals so the registry isn’t just another bookshelf of reports. If the state punts the cost, private philanthropy and public‑private research partnerships can shoulder early work. Emma Heming Willis deserves credit for forcing a conversation that needed to happen. Now Sacramento should answer with policy that helps patients without letting bureaucracy run wild.
